Finally an update, albeit nothing we didn't already know.
A couple of points of interest - I assume that these trials are Phase I (?) as it announces 'The best candidate will be advanced into Phase II/III'. Given successful Phase I (?) outcome and moving to Phase II/III, comercialisation/revenue if all goes to plan, will be quite a way down the track. I have read this announcement several times now and I can't help but be reminded of the fact that this company is still a speculative play with references like 'appeared to be', 'has the potential', 'could be' and 'may turn out to be'. Whilst all these references should be read in context and are necessary, imho, I feel this announcement could have been structured with a slightly more positive, uplifting edge.
Given the current economic environment, the next few weeks should pose an opportunity to acquire more shares for an obviously longer term investment.
An update is an update, and I am sure this will be the first of many more to surface over the next 12 months in relation to Poh's multiple projects under development.
- Forums
- ASX - By Stock
- AVE
- ann - out
ann - out, page-3
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $2.565K | 874.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 40547400 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39021116 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 40547400 | 0.002 |
30 | 74217741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39021116 | 27 |
0.004 | 16680899 | 15 |
0.005 | 10825266 | 10 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 15.59pm 12/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online